Background:

          Read Dr. Rich's bio

Education:

• BChem. - University of Minnesota
• PhD 1968 Organic Chemistry - Cornell University
• Postdoctoral - Cornell University
• Postdoctoral - Stanford University

• 1. Discovery of Nonpeptide, Peptidomimetic Peptidase Inhibitors that Target Alternate Enzyme Active Site Conformations. D.H. Rich, M.G. Bursavich, and M. Angels Estiarte, Biopolymers (Peptide Science), 66, 115-125.
• 2. Solution and Solid Phase Synthesis of Nonpeptide Peptidomimetic Aspartic Peptidase Inhibitors. M.G. Bursavich and D.H. Rich, Peptides: The Wave of the Future, Proceedings of the Second International and the Seventeenth American Peptide Symposium, San Diego, CA, June 9-14, 2001 (2002), 537-538.
• 3. Synthetic Progress Towards a TMC-95 Analogue as a Potential Proteasome Inhibitor. M.A. Estiarte, A.M. Elder, and D.H. Rich, Peptides: The Wave of the Future, Proceedings of the Second International and the Seventeenth American Peptide Symposium, San Diego, CA, June 9-14, 2001 (2002), 532-533.
• 4. One-pot of Azides to Protected Guanidines via the Staudinger Reduction; Synthesis and Utilization of the Phe-Arg Hydroxyethyelene Dipeptide Isostere. M. Brewer and D.H. Rich, Peptides: The Wave of the Future, Proceedings of the Second International and the Seventeenth American Peptide Symposium, San Diego, CA, June 9-14, 2001 (2002), 40-41.
• 5. Sequencing Hydroxyethylamine-Containing Peptides via Edman Degradation. M. Brewer, T. Oost, C. Sukonpan, M. Pereckas, and D.H. Rich, Organic Letters, 4(20), 3469-3472 (2002).
• 6. Structural Basis for BABIM Inhibition of Botulinum Neurotoxin Type B Protease [Erratum for J. Am. Chem. Soc. 2000, 122, 11268-11269].] M.A. Hanson, T.K. Oost, C. Sukonpan, and D.H. Rich, Journal of the American Chemical Society, 124(34), 10248 (2002).
• 7. Peptidomimetics for Drug Design. M.A. Estiarte and D.H. Rich, in Burger's Medicinal Chemistry, 6th Edition. Editor-in-chief, Donald Abraham. John Wiley & Sons, Inc. NY, NY, 2003, Vol. 1, pp 633-685.